Altamira Therapeutics Ltd - CYTO Sotuvning sof marjinal rentabelligi

altamiratherapeutics.com (CYTO) grafik logotipi

Altamira Therapeutics (CYTO) tashqi mojarolarni neytrallovchi biomeditsinaning gumanitar holati tufayli barqaror muhitda faoliyat yuritadi. Sof foyda marjasi xarajatlarning samarali boshqaruvini namoyish etadi, bunda 0.00 ushbu ko'rsatkichning bazaviy darajasini aks ettiradi. Daromadlilik noyob RNA platformalarining qulay litsenziyalashiga asoslangan, garchi operatsion komponent uchinchi tomon CRO va CMO pudratchilariga tayanib ishlasa-da.

altamiratherapeutics.com (CYTO) Sof foyda bo'yicha sotuv rentabelligi: 04.07.2022 - 04.01.2025 davri uchun

altamiratherapeutics.com (CYTO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning dastlabki tahlili:altamiratherapeutics.com, CYTO
Altamira Therapeutics ishlab chiqargan mahsulot

Yuqori sifatli emitentlarni tanlash fundamental samaradorlik koeffitsiyentlarining qat'iy tahliliga asoslangan. Ushbu metrika har bir dollar daromadning sof foyda ulushini belgilab, biznesning yakuniy daromadliligini aks ettiradi. Altamira Therapeutics (CYTO) uchun birjadan tashqari segmentdagi past narx belgilash imkoniyati ushbu qiymatning o'sishini cheklaydi. Patent daromadlarining yo'qligi foydaga qo'shimcha bosim o'tkazadi. Sof foyda marjasi tendentsiyasi kompaniyaning operatsion barqarorligini ob'ektiv baholash imkonini beradi.

Altamira Therapeutics kimlar bilan raqobatlashadi

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sof marja Ligand (LGND)|Sotuvning sof marjinal rentabelligi amneal.com (AMRX)|Sotuvning sof marjinal rentabelligi PRGO (perrigo.com)|Alvotech SA (ALVO) - Sof marja|Liquidia Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Sof marja|Sotuvning sof rentabelligi MNKD|Sof marja Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi SPRY|TBPH - Sof marja|Aquestive Pharma - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi scpharmaceuticals.com SCPH|Tectonic - Sotuvning sof marjinal rentabelligi|TNXP - Sotuvning sof marjinal rentabelligi|SXTC: Sotuvning sof marjinal rentabelligi|Eupraxia Pharma - Sof foyda normasi|BHST (bioharvest.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi EXOZ (invizyne.com)|Sotuvning sof marjinal rentabelligi ORMP|Kompaniya sotuv marjasi Entera Bio|Sotuvning sof marjinal rentabelligi HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Sof marja|Cumberland Corp - Sotuvning sof marjinal rentabelligi|QNTM - Sotuvning sof marjinal rentabelligi|FibroGen, Inc. (FGEN) - Sof marja|TELO: Kompaniyaning sof rentabelligi|RANI (Rani Therapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sof marja synergychc.com SNYR|Sof marja Rallybio Corp. (RLYB)|LEXX - Sof marja|Sotuvning sof marjinal rentabelligi PULM (pulmatrix.com)|Kompaniyaning sof rentabelligi PTHL (Pheton)|APM - Sof marja|Kompaniya sotuv marjasi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Sof marja|TNF Pharma (TNFA) - Sotuvning sof marjinal rentabelligi|YCBD (cbdmd.com) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi PainReform (PRFX)|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma